Unlocking the Future of Gene Editing:
Key Concepts and Breakthroughs in CRISPR
About this webinar
This webinar will provide an overview of clustered regularly interspaced short palindromic repeats (CRISPR) prime editing, a groundbreaking genome-editing technology that offers unprecedented accuracy and versatility in modifying genetic material.
The expert speaker will begin by exploring the basic principles behind prime editing, highlighting its potential for precise DNA alterations without introducing double-strand breaks. The second part of the webinar will focus on how the integration of prime editing into research and therapeutic applications can be supported, offering tailored tools, services and resources that enable seamless implementation.
This webinar will help attendees gain insights into the latest advancements in prime editing and how innovative solutions can help accelerate progress in this exciting field.
Register for this webinar today to understand the potential of CRISPR-based gene editing for research and therapeutic applications.
Who should attend
- Gene and cell therapy development
- Researchers interested in latest advancements in gene editing technologies and their applications
- Researchers seeking to integrate CRISPR-based technologies in their projects and workflows
What you will learn
- Core principles of CRISPR prime editing and its advantages over traditional gene-editing technologies
- How critical tools and support can enhance the application of prime editing in various research domains
- Technological advancements that enhance the accuracy and efficiency of prime editing, making it a superior method for precise DNA alterations
Featured Speakers
Juliana Campo Garcia
Juliana Campo Garcia has a background in neurobiology and immunology, where she focused on the characterization of regenerative niches in the adult brain and investigated the effects of invading immune cells on neural stem cells.
Since joining GenScript as Field Application Scientist she has specialized in RNA and CRISPR technologies, expanding her knowledge base in order to provide expert technical support to customers.
Partner for this event
GenScript
GenScript is the leading contract research organization in the world providing gene, peptide, protein, CRISPR, and antibody. Since its foundation in 2002, GenScript has grown exponentially through partnerships with scientists conducting fundamental life science research, translational biomedical research, and early stage pharmaceutical development. The company is recognized as having built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, peptide synthesis, custom antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to make people and nature healthier through biotechnology by scripting possibilities.